Targeting and Blockades of Advanced and Metastatic Breast Cancer with Trispecific or Dual Bispecific Antibodies Non-Covalently Bound on Mpegylated Nanocarriers Loaded with Docetaxel and Pictilisib for Synergistic Therapy and Circumventing the Resistance(1/3)

  • Sheu, Ming-Thau (PI)

Project: A - Government Institutionb - National Science and Technology Council

Project Details

Effective start/end date8/1/187/31/19


  • Trastuzumab
  • Pertuzumab
  • Pictilisib
  • Docetaxel
  • Anti-HER2IV/anti-mPEG Bispecific Antibody
  • Synergistic combination